Study of MP0533 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Status:
Recruiting
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and preliminary activity
of MP0533 in patients with relapsed/refractory acute myeloid leukemia (AML) or
myelodysplastic syndrome (MDS)